Title

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.

Document Type

Journal Article

Publication Date

1-9-2018

Journal

Journal of Clinical Oncology

DOI

10.1200/JCO.2017.74.3179

Peer Reviewed

1

Find in your library

Share

COinS